Metabolic pathways of Alternative Lengthening of Telomeres in pan-carcinoma
Open Access
- 21 February 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314012
Abstract
Alternative Lengthening of Telomeres (ALT) is a telomerase-independent mechanism deployed by several aggressive cancers to maintain telomere length. This contributes to their malignancy and resistance to conventional therapies. In prior studies, we have identified key proteins linked to the ALT process using multi-omic data integration strategies. In this work, we combined metabolomic datasets with our earlier results to identify targetable metabolic pathways for ALT-positive tumors. 39 ALT-related proteins were found to interact with 42 different metabolites in our analysis. Additional networking analysis revealed a complex interaction between metabolites and ALT-related proteins, suggesting that pan-cancer oncogenes may have an impact on these pathways. Three metabolic pathways have been primarily related with the ALT mechanism: purine metabolism, cysteine and methionine metabolism, and nicotinate and nicotinamide metabolism. Lastly, we prioritized FDA-approved drugs (azathioprine, thioguanine, and mercaptopurine) that could target ALT-positive tumors through purine metabolism. This work provides a wide perspective of the metabolomic pathways associated with ALT and reveals potential therapeutic targets that require further experimental validation.Keywords
Funding Information
- Cintana (This work was supported by Cintana Education (https://www.cintana.com/) as part of the Research Call 2 funding opportunity. The authors I.A.-C., J.G.-C., L.P.-Z., and S.G. received this award. No authors received salary or other funding from commercial companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.)
- UIDE (This study was also supported by UIDE's internal funding program (grant number: UIDE-DGI-MAT-PI-FEC-22-02).)
This publication has 78 references indexed in Scilit:
- DNMT1: A key drug target in triple-negative breast cancerSeminars in Cancer Biology, 2021
- CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional CoactivatorTrends in Cell Biology, 2021
- NAD+-mediated regulation of mammalian base excision repairDNA Repair, 2020
- Systematic mapping of protein–metabolite interactions with mass spectrometry-based techniquesCurrent Opinion in Biotechnology, 2020
- Sulfur metabolism and its contribution to malignancy2019
- A New View into the Regulation of Purine Metabolism: The PurinosomeTrends in Biochemical Sciences, 2017
- NAD+ salvage pathway in cancer metabolism and therapyPharmacological Research, 2016
- Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1Journal of Medicinal Chemistry, 2016
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer SubtypesThe American Journal of Pathology, 2011
- Clinical pharmacology and pharmacogenetics of thiopurinesEuropean Journal of Clinical Pharmacology, 2008